User login
Article Type
Changed
Display Headline
Jeffrey A. Cohen, MD, Describes His Comparison of Alemtuzumab and Interferon Beta-1a in Patients With Multiple Sclerosis
To read the accompanying article, please click here.
Audio / Podcast
Issue
Neurology Reviews - 20(6)
Topics
Legacy Keywords
jeffrey cohen, multiple sclerosis, interferon, alemtuzumab, neurology reviewsjeffrey cohen, multiple sclerosis, interferon, alemtuzumab, neurology reviews
Audio / Podcast
Audio / Podcast
To read the accompanying article, please click here.
To read the accompanying article, please click here.
Issue
Neurology Reviews - 20(6)
Issue
Neurology Reviews - 20(6)
Topics
Article Type
Display Headline
Jeffrey A. Cohen, MD, Describes His Comparison of Alemtuzumab and Interferon Beta-1a in Patients With Multiple Sclerosis
Display Headline
Jeffrey A. Cohen, MD, Describes His Comparison of Alemtuzumab and Interferon Beta-1a in Patients With Multiple Sclerosis
Legacy Keywords
jeffrey cohen, multiple sclerosis, interferon, alemtuzumab, neurology reviewsjeffrey cohen, multiple sclerosis, interferon, alemtuzumab, neurology reviews
Legacy Keywords
jeffrey cohen, multiple sclerosis, interferon, alemtuzumab, neurology reviewsjeffrey cohen, multiple sclerosis, interferon, alemtuzumab, neurology reviews
Article Source
PURLs Copyright
Inside the Article
